| 摘要 |
<p>The present invention discloses compounds of general formula (1) wherein, R11 represents a 5- or 6-membered monocyclic heteroaryl group containing at least one nitrogen, or a 5- or 6-membered monocyclic heteroaryl group containing at least one nitrogen as the N-oxide; one of R?6 and R7¿ represents hydrogen, and the other represents R'-C=O or CR'=NOR'', wherein R' and R'' each independently may be hydrogen, C¿1-8-?alkyl which may be substituted one or more times with OH, C2-6-alkenyl which may be substituted one or more times with OH, C2-6-alkynyl which may be substituted one or more times with OH, or phenyl which may be substituted one or more times with OH; provided however that when R'' represents hydrogen, C1-8-alkyl, C2-6-alkenyl or C2-6-alkynyl then R?11¿ represents a 5- or 6-membered monocyclic heteroaryl containing at least one nitrogen as the N-oxide; or a pharmaceutically acceptable salt thereof. The compounds of the invention are useful as GABA¿A? receptor complex modulators.</p> |
